Purple sweet potato colour-a potential therapy for galactosemia?

International Journal of Food Sciences and Nutrition

Volumn 65, Issue 4, 2014, Pages 391-393

  Timson, David J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Anthocyanin; Galactose 1 phosphate uridylyltransferase deficiency; Galactosemia; Inherited metabolic disease; Oxidative stress; Sweet potato

Indexed keywords

ANTHOCYANIN; ANTIOXIDANT; PIGMENT; PLANT EXTRACT;

ACETYLATION; ANALYSIS; ANIMAL; CHEMISTRY; DIET SUPPLEMENTATION; DIET THERAPY; GALACTOSEMIA; HUMAN; METABOLISM; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT TUBER; SWEET POTATO;

ACETYLATION; ANIMALS; ANTHOCYANINS; ANTIOXIDANTS; DIETARY SUPPLEMENTS; GALACTOSEMIAS; HUMANS; IPOMOEA BATATAS; OXIDATIVE STRESS; PHYTOTHERAPY; PIGMENTS, BIOLOGICAL; PLANT EXTRACTS; PLANT TUBERS;

EID: 84901029938     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2013.860586     Document Type: Review

References (34)

1. Bang YL, Nguyen TT, Trinh TT, Kim YJ, Song J, Song YH. 2009. Functional analysis of mutations in UDP-galactose-4-epimerase (GALE) associated with galactosemia in Korean patients using mammalian GALE-null cells. FEBS J 276:1952-1961.
2. Bosch AM. 2006. Classical galactosaemia revisited. J Inherit Metab Dis 29:516-525.
3. Bosch AM, Bakker HD, van Gennip AH, van Kempen JV, Wanders RJ, Wijburg FA. 2002. Clinical features of galactokinase deficiency: a review of the literature. J Inherit Metab Dis 25:629-634.
4. Fridovich-Keil JL. 2006. Galactosemia: the good, the bad, and the unknown. J Cell Physiol 209:701-705.
5. Fridovich-Keil JL, Jinks-Robertson S. 1993. A yeast expression system for human galactose-1-phosphate uridylyltransferase. Proc Natl Acad Sci USA 90:398-402.
6. Gleason L, Rasberry M, van Calcar S. 2000. Understanding galactosemia-a diet guide. Biochemical genetics program. Madison, WI: University of Wisconsin-Madison.
7. Jumbo-Lucioni PP, Hopson ML, Hang D, Liang Y, Jones DP, Fridovich-Keil JL. 2013a. Oxidative stress contributes to outcome severity in a Drosophila melanogaster model of classic galactosemia. Dis Model Mech 6:84-94.
8. Jumbo-Lucioni PP, Ryan EL, Hopson M, Bishop H, Weitner T, Tovmasyan A, Spasojevic I, et al. 2013b. Manganese-based superoxide dismutase mimics modify both acute and long-term outcome severity in a Drosophila melanogaster model of classic galactosemia. Antioxid Redox Signal, in press. doi: 10.1089/ars.2012. 5122.
9. Kano M, Takayanagi T, Harada K, Makino K, Ishikawa F. 2005. Antioxidative activity of anthocyanins from purple sweet potato, Ipomoera batatas cultivar Ayamurasaki. Biosci Biotechnol Biochem 69:979-988.
10. Kotecha PM, Kadam SS. 1998. Sweet potato. In: Salunkhe DK, Kadam SS, editors. Handbook of vegetable science and technology: production, compostion, storage, and processing. New York: CRC Press. p 71-98.
11. Kushner RF, Ryan EL, Sefton JM, Sanders RD, Lucioni PJ, Moberg KH, Fridovich-Keil JL. 2010. A Drosophila melanogaster model of classic galactosemia. Dis Model Mech 3:618-627.
12. Leslie ND, Yager KL, McNamara PD, Segal S. 1996. A mouse model of galactose-1-phosphate uridyl transferase deficiency. Biochem Mol Med 59:7-12.
13. Liu Y, Xia B, Gleason TJ, Castaneda U, He M, Berry GT, Fridovich-Keil JL. 2012. N-and O-linked glycosylation of total plasma glycoproteins in galactosemia. Mol Genet Metab 106:442-454.
14. Lu J, Wu DM, Zheng YL, Hu B, Zhang ZF. 2010. Purple sweet potato color alleviates D-galactose-induced brain aging in old mice by promoting survival of neurons via PI3K pathway and inhibiting cytochrome C-mediated apoptosis. Brain Pathol 20:598-612.
15. McCorvie TJ, Gleason TJ, Fridovich-Keil JL, Timson DJ. 2013. Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia. Biochim Biophys Acta 1832:1279-1293.
16. McCorvie TJ, Liu Y, Frazer A, Gleason TJ, Fridovich-Keil JL, Timson DJ. 2012. Altered cofactor binding affects stability and activity of human UDP-galactose 4-epimerase: implications for type III galacto-semia. Biochim Biophys Acta 1822:1516-1526.
17. McCorvie TJ, Timson DJ. 2011. Structural and molecular biology of type I galactosemia: disease-associated mutations. IUBMB Life 63: 949-954.
18. McCorvie TJ, Timson DJ. 2013. In silico prediction of the effects of mutations in the human UDP-galactose 4-epimerase gene: Towards a predictive framework for type III galactosemia. Gene 524:95-104.
19. Oki T, Masuda M, Furuta S, Nishiba Y, Terahara N, Suda I. 2002. Involvement of anthocyanins and other phenolic compounds in radical-scavenging activity of purple-fleshed sweet potato cultivars. J Food Sci 67:1752-1756.
20. Philpott M, Gould KS, Markham KR, Lewthwaite SL, Ferguson LR. 2003. Enhanced coloration reveals high antioxidant potential in new sweetpotato cultivars. J Sci Food Agric 83:1076-1082.
21. Quimby BB, Alano A, Almashanu S, DeSandro AM, Cowan TM, Fridovich-Keil JL. 1997. Characterization of two mutations associated with epimerase-deficiency galactosemia, by use of a yeast expression system for human UDP-galactose-4-epimerase. Am J Hum Genet 61: 590-598.
22. Riehman K, Crews C, Fridovich-Keil JL. 2001. Relationship between genotype, activity, and galactose sensitivity in yeast expressing patient alleles of human galactose-1-phosphate uridylyltransferase. J Biol Chem 276:10634-10640.
23. Sanders RD, Sefton JM, Moberg KH, Fridovich-Keil JL. 2010. UDP-galactose 4 epimerase (GALE) is essential for development of Drosophila melanogaster. Dis Model Mech 3:628-638.
24. Shan Q, Lu J, Zheng Y, Li J, Zhou Z, Hu B, Zhang Z, et al. 2009. Purple sweet potato color ameliorates cognition deficits and attenuates oxidative damage and inflammation in aging mouse brain induced by D-galactose. J Biomed Biotechnol 2009:564737. doi: 10.1155/2009/564737.
25. Slepak T, Tang M, Addo F, Lai K. 2005. Intracellular galactose-1- phosphate accumulation leads to environmental stress response in yeast model. Mol Genet Metab 86:360-371.
26. Tang M, Odejinmi SI, Vankayalapati H, Wierenga KJ, Lai K. 2012. Innovative therapy for classic galactosemia-tale of two HTS. Mol Genet Metab 105:44-55.
27. Tang M, Wierenga K, Elsas LJ, Lai K. 2010. Molecular and biochemical characterization of human galactokinase and its small molecule inhibitors. Chem Biol Interact 188:376-385.
28. Terahara N, Shimizu T, Kato Y, Nakamura M, Maitani T, Yamaguchi M, Goda Y. 1999. Six diacylated anthocyanins from the storage roots of purple sweet potato, Ipomoea batatas. Biosci Biotechnol Biochem 63: 1420-1424.
29. Timson DJ. 2006. The structural and molecular biology of type III galactosemia. IUBMB Life 58:83-89.
30. 2-ATPase activity. Pharmacol Toxicol 91:254-257.
31. Wasilenko J, Fridovich-Keil JL. 2006. Relationship between UDP-galactose 4-epimerase activity and galactose sensitivity in yeast. J Biol Chem 281:8443-8449.
32. Wu DM, Lu J, Zheng YL, Zhou Z, Shan Q, Ma DF. 2008. Purple sweet potato color repairs D-galactose-induced spatial learning and memory impairment by regulating the expression of synaptic proteins. Neurobiol Learn Mem 90:19-27.
33. Zhang ZF, Fan SH, Zheng YL, Lu J, Wu DM, Shan Q, Hu B. 2009. Purple sweet potato color attenuates oxidative stress and inflammatory response induced by D-galactose in mouse liver. Food Chem Toxicol 47:496-501.
34. Zhang ZF, Lu J, Zheng YL, Hu B, Fan SH, Wu DM, Zheng ZH, et al. 2010. Purple sweet potato color protects mouse liver against D-galactose-induced apoptosis via inhibiting caspase-3 activation and enhancing PI3K/Akt pathway. Food Chem Toxicol 48:2500-2507.